#ipcalabs search results

#IPCALABS Cmp- 1529 Most Powerful growth and rerating trigger from their latest Q3FY26 Concall 👇 U.S. Portfolio Rebuild and Unichem Margin Normalisation This is the real game changer. Ipca’s Own U.S. Launch Ramp Has Just Begun 35 registrations Only 5 commercialized 5-7 more


COMING UP @ 2PM | #IpcaLabs snaps up Unichem but the street isn't enthused; SII increases its investment in Biocon biologics; #MankindPharma gets ready to hit D-Street. @SurabhiUpadhyay discusses the pharma moves with @ekta_batra on #WhoMovedTheMarket #biocon #pharmacompanies


Standout Brokerage Reports | @Macquarie has an Outperform rating for #AuroPharma and a neutral rating on #IPCALabs. On #Aurobindo and @drreddys, the brokerage says cos could surprise positively in #Q4FY23. @nimeshscnbc with today's standout brokerage report on pharmas #pharma


#IpcaLabs to license cancer, autoimmune disorder drug to US firm BSS @jpullokaran buff.ly/3Nrv1cG

CNBCTV18News's tweet image. #IpcaLabs to license cancer, autoimmune disorder drug to US firm BSS

@jpullokaran

buff.ly/3Nrv1cG

📢 Exciting news for Ipca Labs! Their manufacturing facility gets a thumbs-up from US FDA, and their shares soar to a 52-week high. 🚀💊 Know More: zeebiz.com/markets/stocks… #IpcaLabs #FDA #Pharma


#IPCALABS from 1650 to 1750+ Swift move in 4 trading days

5Man_Commander's tweet image. #IPCALABS from 1650 to 1750+ 

Swift move in 4 trading days

HDFC Sec on IPCA Labs Initiate Buy with TP of Rs 1800 Steady India growth; exports rely on Unichem synergy API business to recover from FY26 Focus on brand-building in India Unichem integration remains key #IPCALabs


#MarketHeadlines * Gujarat announces new dividend & bonus policy, state PSU stocks up * #IPCALabs corrects after Unichem deal; Mgmt expects ₹1,800 cr revenue * #MCX slumps over 4% after CEO's resignation * #MahindraCIE up 9% after posting strong Q4 numbers


SECTOR - PHARMA #OVFB Candidate ✅Looking All Set for a FRESH ATH ✅Attempting a BO of 2 Months of CONSOLIDATION, for the 3rd time ✅Enjoying SECTORAL Tailwinds ✅VOLUME BUILTP Clearly Visible #IPCALABS (DCP - 1276) #WATCHLIST

NiveshakBharat's tweet image. SECTOR - PHARMA

#OVFB Candidate

✅Looking All Set for a FRESH ATH 
✅Attempting a BO of 2 Months of 
       CONSOLIDATION, for the 3rd time
✅Enjoying SECTORAL Tailwinds
✅VOLUME BUILTP Clearly Visible 

#IPCALABS (DCP - 1276)

#WATCHLIST

#BrokerageRadar: #Emkay initiates 'Buy' on #IPCALabs with Price Target of Rs 1700 For more, visit our Research Reports section: bit.ly/3HrgiME

NDTVProfitIndia's tweet image. #BrokerageRadar: #Emkay initiates 'Buy' on #IPCALabs with Price Target of Rs 1700

For more, visit our Research Reports section: bit.ly/3HrgiME

Pharma Stocks In Focus - #Lupin secures tentative #USFDA approval for HIV drugs with US sales of $16.2 Bn - #IPCALabs signs oncology and inflammation biosimilar tech transfer pact with BioSimilar Sciences PR #CNBCTV18Market @ekta_batra @CNBCTV18News


#Q1WithETNOW | IPCA Labs Q1: Cons PAT up 21.3% YoY, revenue rises 10.3% #IPCALabs #StockMarket #stockmarketsindia

ETNOWlive's tweet image. #Q1WithETNOW | IPCA Labs Q1: Cons PAT up 21.3% YoY, revenue rises 10.3%

#IPCALabs #StockMarket #stockmarketsindia

IPCA LABs 🪻🌸 Current Level: 1327 Zig-Zag Support: 1308-5 High Volatile stock with Tight Range formation Hold with SL 1299 Buy: Above 1355+ #ipcalabs

BaijuBears's tweet image. IPCA LABs 🪻🌸

Current Level: 1327
Zig-Zag Support: 1308-5 
High Volatile stock with Tight Range formation
Hold with SL 1299
Buy: Above 1355+

#ipcalabs
This post is unavailable.

#IPCALABS 100 POINT MOVE - ENJOY #BHE MAGIC

chartians's tweet image. #IPCALABS 100 POINT MOVE - ENJOY #BHE MAGIC

Bookmark this #Ipcalabs cmp 1135 ⭐️📌 If 1090 is defended on lower side, what im looking at is a base that can reward 20/25%+ Expecting 1500+



Reality Check: While #IpcaLabs, #AurobindoPharma, and #ZydusLifesciences lead the charge, the "growth" is actually fueled by defensive rotation and the fact that raw material shortages are about to turn your medicine cabinet into a high-end luxury collection. 🧪🤡 #NiftyPharma


Ipca Labs Ipca transfers monoclonal antibody biosimilar tech to BSS; US manufacturing in Puerto Rico; launch targeted 2027. #IpcaLabs #Investor #Niftycrash #OptionsTreding #Investing #Breaking #Nifty #BreakingNews

subrata_minu's tweet image. Ipca Labs

Ipca transfers monoclonal antibody biosimilar tech to BSS; US manufacturing in Puerto Rico; launch targeted 2027.

#IpcaLabs
#Investor #Niftycrash #OptionsTreding #Investing #Breaking #Nifty #BreakingNews

#IpcaLabs to license cancer, autoimmune disorder drug to US firm BSS @jpullokaran buff.ly/3Nrv1cG

CNBCTV18News's tweet image. #IpcaLabs to license cancer, autoimmune disorder drug to US firm BSS

@jpullokaran

buff.ly/3Nrv1cG

#NewsAlert | Ipca Laboratories in tech transfer pact of Monoclonal Antibody biosimilar #IpcaLabs #Pharma #StockMarket

ETNOWlive's tweet image. #NewsAlert | Ipca Laboratories in tech transfer pact of Monoclonal Antibody biosimilar

#IpcaLabs #Pharma #StockMarket

Ipca Laboratories update: 👉 Ipca Laboratories announces a technology transfer agreement with BioSimilar Sciences PR LLC. #IpcaLabs #BioSimilars 👉 Focused on monoclonal antibody biosimilar development. #Biotech #MonoclonalAntibodies 👉 Targets a US market worth USD 4B+.


From pharma utility training to joining Ipca Laboratories! 🚀 Congrats to Kunal Shinde on his placement as Utility Services Assistant. Proof that the right skills open the right doors. #PharmaJobs #PlacementSuccess #IpcaLabs #ThePharmaDaily

mitaliskjain's tweet image. From pharma utility training to joining Ipca Laboratories! 🚀
Congrats to Kunal Shinde on his placement as Utility Services Assistant.
Proof that the right skills open the right doors.

#PharmaJobs #PlacementSuccess #IpcaLabs #ThePharmaDaily

#ipcalabs held a conference call on August 12, 2025, to discuss Q1 FY26 earnings. The company reported a 10% growth in domestic business and improved standalone margins. However, challenges in the US market and Unichem's performance affected overall


#Q1WithETNOW | IPCA Labs Q1: Cons PAT up 21.3% YoY, revenue rises 10.3% #IPCALabs #StockMarket #stockmarketsindia

ETNOWlive's tweet image. #Q1WithETNOW | IPCA Labs Q1: Cons PAT up 21.3% YoY, revenue rises 10.3%

#IPCALabs #StockMarket #stockmarketsindia

#IpcaLabs report its #Q1Results ; 👉Net Profit Up 21.3% At ₹233.2 Cr Vs ₹192.2 Cr (YoY). 👉Revenue Up 10.3% At ₹2,309 Cr Vs ₹2,092.6 Cr (YoY). 👉EBITDA Up 6.1% At ₹416.5 Cr Vs ₹392.5 Cr (YoY). 👉Margin At 18% Vs 18.8% (YoY). ■□■□■


*ट्रम्प की दवाओं पर 250% टैरिफ लगाने की धमकी:* बोले- दवाइयां अमेरिका में ही बनाई जाएं; US में 40% दवाएं भारत से जाती हैं All Nifty Pharma stocks under pressure #NiftyPharma #Trumptariffs #IPCAlabs #Biocon #AjantaPharma #ZydusLife #DivisLab x.com/mortgagereels/…


#IPCA LAB Results are Awesome 🤩 Price action on charts also good 🔥🔥 If sustain closing above 1500 this week then 30% move expected

TarakeshHero's tweet image. #IPCA LAB

Results are Awesome 🤩 

Price action on charts also good 🔥🔥

If sustain closing above 1500 this week then 30% move expected


Namaste @SandeepKrJainTS from India How are you doing? Can you share your view on #IPCALABS?


#IPCALABS @ipca Awaiting for BREAKOUT?


IPCA Laboratories shares up as the USFDA issued an EIR with Voluntary Action Initiated for their manufacturing facility in SEZ Indore, Pithampur. #IPCA #IPCAlabs #USFDA #stockmarkets

BenzingaIndia's tweet image. IPCA Laboratories shares up as the USFDA issued an EIR with Voluntary Action Initiated for their manufacturing facility in SEZ Indore, Pithampur.

#IPCA #IPCAlabs #USFDA #stockmarkets

Market returns #IpcaLabs: 1Y: -27.87% 2Y: -29.46% Generating such negative returns in a bull market may take a heavy toll on the conviction that it is easy to make money in the #stockmarket.

marginvalue's tweet image. Market returns #IpcaLabs:

1Y: -27.87%
2Y: -29.46%

Generating such negative returns in a bull market may take a heavy toll on the conviction that it is easy to make money in the #stockmarket.

#ipcalabs - showing strength and on BO. PS : Only for learning purposes. Consult your financial advisor before investing.

Pralhadjana's tweet image. #ipcalabs - showing strength and on BO.

PS : Only for learning purposes. Consult your financial advisor before investing.

What is inflation? This picture itself is self explanatory. #ipcalabs @IPCALabsNews

aridev009's tweet image. What is inflation?

This picture itself is self explanatory.
#ipcalabs @IPCALabsNews

SECTOR - PHARMA #OVFB Candidate ✅Looking All Set for a FRESH ATH ✅Attempting a BO of 2 Months of CONSOLIDATION, for the 3rd time ✅Enjoying SECTORAL Tailwinds ✅VOLUME BUILTP Clearly Visible #IPCALABS (DCP - 1276) #WATCHLIST

NiveshakBharat's tweet image. SECTOR - PHARMA

#OVFB Candidate

✅Looking All Set for a FRESH ATH 
✅Attempting a BO of 2 Months of 
       CONSOLIDATION, for the 3rd time
✅Enjoying SECTORAL Tailwinds
✅VOLUME BUILTP Clearly Visible 

#IPCALABS (DCP - 1276)

#WATCHLIST

#IpcaLabs to license cancer, autoimmune disorder drug to US firm BSS @jpullokaran buff.ly/3Nrv1cG

CNBCTV18News's tweet image. #IpcaLabs to license cancer, autoimmune disorder drug to US firm BSS

@jpullokaran

buff.ly/3Nrv1cG

IPCA Labs looking forward to cross a few slabs. #ipcalabs #stocks #stocksgivenbymethisweekinsmartplusfinancialweekly Ipca Laboratories Ltd. engages in the manufacturing, marketing, research, and development of pharmaceutical products. Ipca Laboratories Ltd. Closing price is

candles_happy's tweet image. IPCA Labs looking forward to cross a few slabs.
#ipcalabs 
#stocks 
#stocksgivenbymethisweekinsmartplusfinancialweekly
Ipca Laboratories Ltd. engages in the manufacturing, marketing, research, and development of pharmaceutical products.

Ipca Laboratories Ltd. Closing price is

monitoring a possible Leveraged, Positional Long Play : #IPCALABS VCP on a shorter time frame.

N4irit's tweet image. monitoring a possible Leveraged, Positional Long Play : #IPCALABS 
VCP on a shorter time frame.
N4irit's tweet image. monitoring a possible Leveraged, Positional Long Play : #IPCALABS 
VCP on a shorter time frame.

Finance News: IPCA Laboratories continues its growth trajectory with a stellar Q2 2023 performance – Net Profit at 145 crore (YoY: +1%) and Revenue soaring to 2034 crore (YoY: +27%). #IPCALabs #QuarterlyResults

bystockbull's tweet image. Finance News:
IPCA Laboratories continues its growth trajectory with a stellar Q2 2023 performance – Net Profit at 145 crore (YoY: +1%) and Revenue soaring to 2034 crore (YoY: +27%). #IPCALabs #QuarterlyResults

🫡🫡🫡 #IpcaLabs

Breakout_trades's tweet image. 🫡🫡🫡

#IpcaLabs

#IpcaLabs Consolidating nicely above 850-870 zone A Trendline Breakout is awaited here!! #Stocks #StockMarket Also look at the tale of that highlighted zone - Two candle story!!!

Breakout_trades's tweet image. #IpcaLabs 

Consolidating nicely above 850-870 zone 

A Trendline Breakout is awaited here!! 

#Stocks #StockMarket 

Also look at the tale of that highlighted zone - Two candle story!!!


Pharma run-up is still going strong🔥. Here are some of the stock analysis: 1. #GSPL 2. #HCLTECH 3. #IpcaLabs #BREAKOUTSTOCKS #PharmaIndustry #StockMarket #Nifty #swingtrade #investing #StockMarketindia #StocksToWatch

Herobir_tr's tweet image. Pharma run-up is still going strong🔥. Here are some of the stock analysis:
1. #GSPL 
2. #HCLTECH
3. #IpcaLabs 

#BREAKOUTSTOCKS #PharmaIndustry #StockMarket #Nifty #swingtrade #investing #StockMarketindia #StocksToWatch
Herobir_tr's tweet image. Pharma run-up is still going strong🔥. Here are some of the stock analysis:
1. #GSPL 
2. #HCLTECH
3. #IpcaLabs 

#BREAKOUTSTOCKS #PharmaIndustry #StockMarket #Nifty #swingtrade #investing #StockMarketindia #StocksToWatch
Herobir_tr's tweet image. Pharma run-up is still going strong🔥. Here are some of the stock analysis:
1. #GSPL 
2. #HCLTECH
3. #IpcaLabs 

#BREAKOUTSTOCKS #PharmaIndustry #StockMarket #Nifty #swingtrade #investing #StockMarketindia #StocksToWatch

💊 IPCA Labs Update IPCA Labs is looking strong on the buy side! Critical Level Daily Chart.📈 Keep an eye on this one for potential upside. 🚀 #IPCALabs #StockMarket #TradingView

shalinnijain's tweet image. 💊 IPCA Labs Update
IPCA Labs is looking strong on the buy side! Critical Level Daily Chart.📈 Keep an eye on this one for potential upside. 🚀 #IPCALabs #StockMarket #TradingView

#ipcalabs Cup n handle on wtf Making handle Breakout levels marked @Sahilpahwa09 @nishkumar1977 @VaibhavBhimjiy2

shivamg14221114's tweet image. #ipcalabs 
Cup n handle on wtf 
Making handle 
Breakout levels marked 

@Sahilpahwa09 @nishkumar1977 @VaibhavBhimjiy2

#IPCALabs' revenue at Rs 2,034 crore, up 27% year-on-year. #Q2WithBQ For all the latest earnings updates, visit: bit.ly/37kV0CO

NDTVProfitIndia's tweet image. #IPCALabs' revenue at Rs 2,034 crore, up 27% year-on-year. #Q2WithBQ

For all the latest earnings updates, visit: bit.ly/37kV0CO

#IPCALABS 100 POINT MOVE - ENJOY #BHE MAGIC

chartians's tweet image. #IPCALABS 100 POINT MOVE - ENJOY #BHE MAGIC

Bookmark this #Ipcalabs cmp 1135 ⭐️📌 If 1090 is defended on lower side, what im looking at is a base that can reward 20/25%+ Expecting 1500+



Loading...

Something went wrong.


Something went wrong.